Business
Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines
Berkeley Vincent Photo of Berkeley Vincent ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS1 APRIL 2026 at 16.00 EEST Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines Orion Corporation (“Orion”) has appointed Berkeley Vincent as Executive Vice President, Innovative Medicines and a member of the Orion Executive Team as of 8 April 2026. The appointment is part of a leadership structure ch
About this update from Orion Corp.
[{"type":"image","alt":"Orion Oyj","displaySize":"","headline":null,"caption":"Orion Oyj","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":118,"url":"https://media.zenfs.com/en/globenewswire.com/81ce103a881cae9326d4e01207e6d4b0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oGQKPK6RsO5eTABx1IN6xw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2NQ--/https://media.zenfs.com/en/globenewswire.com/81ce103a881cae9326d4e01207e6d4b0","width":300,"height":118}},"lazy":false},{"type":"text","content":"Berkeley Vincent","length":16,"tagName":"p"},{"type":"image","alt":"Photo of Berkeley Vincent","displaySize":"","headline":null,"caption":"Photo of Berkeley Vincent","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":7952,"height":5304,"url":"https://media.zenfs.com/en/globenewswire.com/8dc5bb2b0b5eed67f6cd5f805f6dcb5a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bw6YvJeoA7fB1vD64elqkA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/8dc5bb2b0b5eed67f6cd5f805f6dcb5a","width":960,"height":640},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/eDt.9cqt2lUf5jDtSg7Ymg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNjAw/https://media.zenfs.com/en/globenewswire.com/8dc5bb2b0b5eed67f6cd5f805f6dcb5a","width":1200,"height":800}}},{"type":"text","content":"ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS1 APRIL 2026 at 16.00 EEST","length":110,"tagName":"p"},{"type":"text","content":"Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines ","length":131,"tagName":"p"},{"type":"text","content":"Orion Corporation (“Orion”) has appointed Berkeley Vincent as Executive Vice President, Innovative Medicines and a member of the Orion Executive Team as of 8 April 2026.","length":169,"tagName":"p"},{"type":"text","content":"The appointment is part of a leadership structure change in which the previously combined role of R&D and Innovative Medicines is split into two dedicated positions. This change reflects the continued growth and maturation of Orion’s Innovative Medicines pipeline and the increasing need to strengthen focus on global commercialization readiness. Outi Vaarala will continue in her role as Executive Vice President, R&D, and as a member...